Tamoxifen Recruiting Phase 2 Trials for Early-Stage Breast Carcinoma / Hormone Receptor Positive Tumor Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02592083Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors